Ganirelix Acetate (Organon USA Inc.)


Welcome to the PulseAid listing for the Ganirelix Acetate drug offered from Organon USA Inc.. This Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Organon USA Inc.
NON-PROPRIETARY NAME: Ganirelix Acetate
SUBSTANCE NAME: GANIRELIX ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1999-07-29
END MARKETING DATE: 0000-00-00


Ganirelix Acetate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGanirelix Acetate from Organon USA Inc.
LABELER NAME: Organon USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(ug/.5mL)
START MARKETING DATE: 1999-07-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0052-0301_a6451f5e-660b-4ae2-93ac-af6902720278
PRODUCT NDC: 0052-0301
APPLICATION NUMBER: NDA021057

Other GANIRELIX ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Organon USA Inc.Ganirelix Acetate